Turkiye Klinikleri Journal of Dental Sciences

.: ORIGINAL RESEARCH
Antirezorptif Ajan Kullanan Hastalardaki Radyografik Bulgular: Retrospektif Değerlendirme: Kesitsel Çalışma
Radiographic Findings in Patients Using Antiresorptive Agents: Retrospective Assessment: Cross-Sectional Study
Aslıhan AKBULUTa
aİstanbul Medipol Üniversitesi Diş Hekimliği Fakültesi, Ağız, Diş ve Çene Radyolojisi ABD, İstanbul, TÜRKİYE
Turkiye Klinikleri J Dental Sci. 2022;28(1):41-51
doi: 10.5336/dentalsci.2021-83512
Article Language: TR
Full Text
ÖZET
Amaç: İlaçlara bağlı çene kemiği osteonekrozu (İÇKON), antirezorptif/ antianjiyogenik ajanların sebep olduğu ciddi problemlerden biridir. Bu çalışmanın amacı, İÇKON'nin panoramik radyografi görüntülerindeki bulguları değerlendirmektir. Gereç ve Yöntemler: Bu retrospektif çalışma, 3.079 hastaya ait veriler üzerinde yapılmıştır ve bu hastalardan 'bifosfonat' veya 'denosumab' grubu antirezorptif ilaç kullanan 40 hastaya ait panoramik radyografileri değerlendirilmiştir. İlacın adı, hangi amaçla kullanıldığı, kullanım şekli ve kullanım süresi kaydedilmiştir. Panoramik radyografi bulguları; osteolizis, kortikal kemik erozyonu, fokal/diffüz kemik sklerozu, sekestr lamina dura kalınlaşması, mandibular kanalın belirginleşmesi, persistan alveoler soket, periodontal aralıkta genişleme, patolojik fraktür olarak incelenmiştir. Bulgular: Radyografik bulguların 60 yaş üstü kadın hastalarda (%85) ve alt çene posterior bölgede daha fazla (%40,8) görüldüğü saptanmıştır. Başta osteolizis (%53,9) olmak üzere, kortikal kemik erozyonu (%36,8) ve periodontal aralıkta genişleme (%34,2) en çok belirlenen bulgulardır. İlaç kullanım süresiyle radyografik bulgu sayısı arasında pozitif yönlü, orta düzeyde ve istatistiksel olarak anlamlı bir ilişki bulunmaktadır (p=0,000; p<0,05). Sekestr görülen olguların yaş ortalaması, görülmeyen olgulardan istatistiksel olarak anlamlı düzeyde yüksektir (p=0,006; p<0,05). Sonuç: İÇKON'ye dair spesifik radyografik bulguların olmamasına rağmen, panoramik radyografi diş hekimine temel radyografik bulgular hakkında değerli bilgiler sunmaktadır. Diş hekimi, antirezorptif ajan kullanan hastaların radyolojik muayenesinde osteolizis, kortikal kemik erozyonu, periodontal aralıkta genişleme, kemik skleroz, persistan alveoler soket, lamina durada kalınlaşma, sekestr ve patolojik fraktür gibi bulgular var ise osteonekroz riskini göz önünde bulundurmalıdır.

Anahtar Kelimeler: Antirezorptif ajan; bifosfonat; denosumab; çene osteonekrozu; panoramik radyografi
ABSTRACT
Objective: Medication-related osteonecrosis of the jaws (MRONJ) is one of the serious problems caused by antiresorptive/antiangiogenic agents. The aim of the study is to evaluate the findings in the panoramic radiography of MRONJ. Material and Methods: This study was carried out on the data of 3079 patients and among these patients, panoramic radiographies of 40 patients using 'Bisphosphonate' or 'Denosumab' group antiresorptives were evaluated. The name, purpose of use, method of usage and duration of the drug used were recorded. Radiographic findings; osteolysis, cortical bone erosion, focal/diffuse bone sclerosis, sequestration, laminadura thickening, persisting alveolar sockets, periodontal space widening, pathological fracture. Results: Findings were found to be more common in female patients over 60 years of age (85%) and in the posterior region of the mandible (40.8%). Firstly osteolysis (53.9%), cortical bone erosion (36.8%), periodontal space widening (34.2%) are the most common findings. There was a positive, moderate and statistically significant relationship between the duration of drug use and the number of radiographic findings (p=0.000; p<0.05). The mean age of the cases with sequestration is statistically significantly higher than the cases with no seen (p=0.006; p<0.05). Conclusion: Although the radiographic findings of MRONJ is nonspecific, panoramic graphy provides valuable data to the dentist about basic radiographic findings. The dentist should consider the risk of osteonecrosis if there are radiographic findings osteolysis, cortical bone erosion, the periodontal space widening, focal/diffuse bone sclerosis, prominent mandibularcanal, persistent alveolar socket, lamina dura thickening, sequestration and pathological fracture in patients using antiresorptive agents.

Keywords: Antiresorptive agents; bisphosphonate; denosumab; jaw osteonecrosis; panoramic radiography
REFERENCES:
  1. Chen JS, Sambrook PN. Antiresorptive therapies for osteoporosis: a clinical overview. Nat Rev Endocrinol. 2011;6;8(2):81-91. [Crossref]  [PubMed] 
  2. Thayer ML. Radiographic evidence of treatment with bisphosphonates. Br Dent J. 2017;222(7):507-10. [Crossref]  [PubMed] 
  3. Duygu Çapar G, Cabbar F, Yalçın GM, Özçakır-Tomruk C. İlaçlara bağlı çene kemiği osteonekrozu: derleme [Medication related jaw osteonecrosis: review]. J Dent Fac Atatürk Uni. 2015;13:118-29. [Link] 
  4. Yazıcı T, Şentürk MF, Koçer G. İlaca bağlı olarak çene kemiklerinde görülen osteonekroz (Mronj) [Medication related osteonecrosis of the jaws (Mronj)] SDÜ Sağlık Bilimleri Enstitüsü Dergisi. 2017;8(2):50-7. [Crossref] 
  5. Öztürk E, Saruhan N. İlaca bağlı olarak çene kemiklerinde görülen osteonekroz (Mronj) [Medication related osteonecrosis of the jaw (Mronj)]. J Biotechnol and Strategic Health Res. 2019;3(1):8-20. [Crossref] 
  6. Cardoso CL, Barros CA, Curra C, Fernandes LM, Franzolin SO, Júnior JS, et al. Radiographic findings in patients with medication-related osteonecrosis of the Jaw. Int J Dent. 2017;2017:319 0301. [Crossref]  [PubMed]  [PMC] 
  7. Hamadeh IS, Ngwa BA, Gong Y. Drug induced osteonecrosis of the jaw. Cancer Treat Rev. 2015;41(5):455-64. [Crossref]  [PubMed] 
  8. Rocha GC, Jaguar GC, Moreira CR, Neves EG, Fonseca FP, Pedreira EN. Radiographic evaluation of maxillofacial region in oncology patients treated with bisphosphonates. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;114(5 Suppl):S19-25. [Crossref]  [PubMed] 
  9. Sipahi-Çalış A, Efeoğlu C, Sezer B, Koca H. Kanser hastalarında bifosfonata bağlı osteonekroz (BRONJ): retrospektif çalışma [Biphosphonate-related osteonecrosis (BRONJ) in cancer patients: retrospective study]. EÜ Dişhek Fak Derg. 2018; 39(1):32-8. [Crossref] 
  10. Kıvrak A, Hakiki H, Çongara-Kıvrak T, Cambazoğlu M. Bifosfonat kullanımına bağlı mandibulada gelişen osteonekroz ve tedavi yaklaşımı: olgu sunumu [Osteonecrosis of the mandible releated to bisphosphonate: report of one case]. A.Ü. Diş Hek Fak Derg. 2017; 44(2):101-8. [Link] 
  11. Ergün S, Güneri P, Koca H. Çene kemiklerinin yeni tehlikesi: bisfosfonatlar [A new threat for the jaws bones: bisphosphonate]. Cumhuriyet Üniv Diş Hek Fak Derg. 2008;11(2):134-9. [Link] 
  12. Soğur E, Önem E, Baksı BG. Bisfosfanat kullanımına bağlı çene kemiğinde gelişen osteonekroz: etyoloji, risk faktörleri, tanı kriterleri ve tedavi alternatifleri [Bisphosphonate-associated osteonecrosis of the jaws: etiology, risk factors, diagnostic criteria, treatment alternatives]. Atatürk Üniv Diş Hek Fak Derg. 2012;22(1):83-95. [Link] 
  13. Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, et al; American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update. J Oral Maxillofac Surg. 2014; 72(10):1938-56. Erratum in: J Oral Maxillofac Surg. 2015;73(7):1440. Erratum in: J Oral Maxillofac Surg. 2015; 73(9):1879. [Crossref]  [PubMed] 
  14. Koth VS, Figueiredo MA, Salum FG, Cherubini K. Interrelationship of clinical, radiographic and haematological features in patients under bisphosphonate therapy. Dentomaxillofac Radiol. 2017; 46(4):20160260. [Crossref]  [PubMed]  [PMC] 
  15. Klingelhöffer C, Klingelhöffer M, Müller S, Ettl T, Wahlmann U. Can dental panoramic radiographic findings serve as indicators for the development of medication-related osteonecrosis of the jaw? Dentomaxillofac Radiol. 2016;45(5):20160065. [Crossref]  [PubMed]  [PMC] 
  16. Phal PM, Myall RW, Assael LA, Weissman JL. Imaging findings of bisphosphonate-associated osteonecrosis of the jaws. AJNR Am J Neuroradiol. 2007;28(6):1139-45. [Crossref]  [PubMed]  [PMC] 
  17. Onur ÖD, Sofuyev N. Çenelerde bifosfonat kullanımına bağlı gelişen osteonekrozdan korunma ve tedavi yöntemleri [Prevention and treatment methods from osteonecrosis due to the use of bisphosphonates in the jaws]. Dergi Bilimsel. 2011:62-8. [Link] 
  18. Onur ÖD, Kurtuluş B, Çevik P. Bifosfonat kullanan hastalarda oral cerrahi uygulamalarda karşı- laşabilecek sorunlar ve tedavisi [Oral complications and treatments in patients receiving bisphosphonates]. İstanbul Üniv Diş Hek Fak Derg. 2009;43(3-4):113-22. [Link] 
  19. Karaçelebi E, Öztürk M. Oral ve maksillofasial cerrahide bifosfonatlar ve bifosfonatla ilişkili çene osteonekrozu tedavisinde yeni yaklaşımlar [Bisp hosphonates and new treatment approachs of bisphosphonate related osteonecrosis of the jaws in oral and maxillofacial surgery]. ADO Klinik Bilimler Derg. 2012;5(4):1052-62. [Link] 
  20. Kalra S, Jain V. Dental complications and management of patients on bisphosphonate therapy: a review article. J Oral Biol Craniofac Res. 2013;3(1):25-30. [Crossref]  [PubMed]  [PMC] 
  21. Soydan SS, Veziroğlu-Şenel F, Araz K. Bifosfonata bağlı olarak çene kemiklerinde gelişen osteonekrozun patogenezi ve tedavisi [Pathogenesis and treatment of bisphosphonate induced osteonecrosis of the jaws]. Hacettepe Diş Hek Fak Derg. 2009;33(3):61-8. [Link] 
  22. Yifat M, Hila E, Avraham H, Inchingolo F, Mortellaro C, Peleg O, et al. Histologic and radiographic characteristics of bone filler under bisphosphonates. J Craniofac Surg. 2019; 30(4):1085-8. [Crossref]  [PubMed] 
  23. Farzeen T, Mirza AA, Tauseef D, Mahar A. Bisphosphanates and the field dentistry. European J Gen Dent. 2014;3(1):11-6. [Crossref] 
  24. American Dental Association Council on Scientific Affairs. Dental management of patients receiving oral bisphosphonate therapy: expert panel recommendations. J Am Dent Assoc. 2006;137(8):1144-50. [Crossref]  [PubMed] 
  25. Borromeo GL, Tsao CE, Darby IB, Ebeling PR. A review of the clinical implications of bisphosphonates in dentistry. Aust Dent J. 2011; 56(1):2-9. [Crossref]  [PubMed] 
  26. Balta O, Kurnaz R, Aytekin K, Aşçı M, Gedikbaş M, Bostan B. Dev hücreli kemik tümöründe denosumab tedavisinin yeri: literatürün gözden geçirilmesi [Denosumab therapy in giant cell bone tumor: review of literature]. Acta Oncologica Turcica. 2017;50(3):250-8. [Crossref] 
  27. Devlin H, Greenwall-Cohen J, Benton J, Goodwin TL, Littlewood A, Horner K. Detecting the earliest radiological signs of bisphosphonate-related osteonecrosis. Br Dent J. 2018; 224(1):26-31. [Crossref]  [PubMed] 
  28. Treister N, Sheehy N, Bae EH, Friedland B, Lerman M, Woo S. Dental panoramic radiographic evaluation in bisphosphonate-associated osteonecrosis of the jaws. Oral Dis. 2009;15(1):88-92. [Crossref]  [PubMed] 
  29. Hutchinson M, O'Ryan F, Chavez V, Lathon PV, Sanchez G, Hatcher DC, et al. Radiographic findings in bisphosphonate-treated patients with stage 0 disease in the absence of bone exposure. J Oral Maxillofac Surg. 2010; 68(9):2232-40. [Crossref]  [PubMed] 
  30. Mücke T, Krestan CR, Mitchell DA, Kirschke JS, Wutzl A. Bisphosphonate and medication-related osteonecrosis of the jaw: a review. Semin Musculoskelet Radiol. 2016;20(3):305-14. [Crossref]  [PubMed] 
  31. Thumbigere-Math V, Sabino MC, Gopalakrishnan R, Huckabay S, Dudek AZ, Basu S, et al. Bisphosphonate-related osteonecrosis of the jaw: clinical features, risk factors, management, and treatment outcomes of 26 patients. J Oral Maxillofac Surg. 2009;67(9): 1904-13. [Crossref]  [PubMed] 
  32. Barngkgei I, Halboub E, Almashraqi A. Effect of bisphosphonate treatment on the jawbone: an exploratory study using periapical and panoramic radiographic evaluation. Oral Radiol. 2019;35(2):159-70. [Crossref]  [PubMed] 

.: Up To Date

.: Process List

Login



Contact


Ortadoğu Reklam Tanıtım Yayıncılık Turizm Eğitim İnşaat Sanayi ve Ticaret A.Ş.

.: Address

Turkocagi Caddesi No:30 06520 Balgat / ANKARA
Phone: +90 312 286 56 56
Fax: +90 312 220 04 70
E-mail: info@turkiyeklinikleri.com

.: Manuscript Editing Department

Phone: +90 312 286 56 56/ 2
E-mail: yaziisleri@turkiyeklinikleri.com

.: English Language Redaction

Phone: +90 312 286 56 56/ 145
E-mail: tkyayindestek@turkiyeklinikleri.com

.: Marketing Sales-Project Department

Phone: +90 312 286 56 56/ 142
E-mail: reklam@turkiyeklinikleri.com

.: Subscription and Public Relations Department

Phone: +90 312 286 56 56/ 118
E-mail: abone@turkiyeklinikleri.com

.: Customer Services

Phone: +90 312 286 56 56/ 118
E-mail: satisdestek@turkiyeklinikleri.com

1. TERMS OF USE

1.1. To use the web pages with http://www.turkiyeklinikleri.com domain name or the websites reached through the sub domain names attached to the domain name (They will be collectively referred as "SITE"), please read the conditions below. If you do not accept these terms, please cease to use the "SITE." "SITE" owner reserves the right to change the information on the website, forms, contents, the "SITE," "SITE" terms of use anytime they want.

1.2. The owner of the "SITE" is Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. (From now on it is going to be referred as "Turkiye Klinikleri", shortly) and it resides at Turkocagi cad. No:30, 06520 Balgat Ankara. The services in the "SITE" are provided by "Turkiye Klinikleri."

1.3. Anyone accessing the "SITE" with or without a fee whether they are a natural person or a legal identity is considered to agree these terms of use. In this contract hereby, "Turkiye Klinikleri" may change the stated terms anytime. These changes will be published in the "SITE" periodically and they will be valid when they are published. Any natural person or legal identity benefiting from and reaching to the "SITE" are considered to be agreed to any change on hereby contract terms done by "Turkiye Klinikleri."

1.4. The "Terms of Use" hereby is published in the website with the last change on March 30th 2014 and the "SITE" is activated by enabling the access to everyone. The "Terms of Use" hereby is also a part of the any "USER Contract" was and/or will be done with the users using "Turkiye Klinikleri" services with or without a fee an inseparable.

2. DEFINITIONS

2.1. "SITE": A website offering different kind of services and context with a certain frame determined by "Turkiye Klinikleri" and it is accessible on-line on http://www.turkiyeklinikleri.com domain name and/or subdomains connected to the domain name.

2.2. USER: A natural person or a legal identity accessing to the "SITE" through online settings.

2.3. LINK: A link enabling to access to another website through the "SITE", the files, the context or through another website to the "SITE", the files and the context.

2.4. CONTEXT: Any visual, literary and auditory images published in the "Turkiye Klinikleri", "SITE" and/or any website or any accessible information, file, picture, number/figures, price, etc.

2.5. "USER CONTRACT": An electronically signed contract between a natural or a legal identity benefiting from special services "Turkiye Klinikleri" will provide and "Turkiye Klinikleri".

3. SCOPE OF THE SERVICES

3.1. "Turkiye Klinikleri" is completely free to determine the scope and quality of the services via the "SITE".

3.2. To benefit the services of "Turkiye Klinikleri" "SITE", the "USER" must deliver the features that will be specified by "Turkiye Klinikleri". "Turkiye Klinikleri" may change this necessity any time single-sided.

3.3. Not for a limited number, the services "Turkiye Klinikleri" will provide through the "SITE" for a certain price or for free are;

- Providing scientific articles, books and informative publications for health industry.

- Providing structural, statistical and editorial support to article preparation stage for scientific journals.

4. GENERAL PROVISIONS

4.1. "Turkiye Klinikleri" is completely free to determine which of the services and contents provided in the "SITE" will be charged.

4.2. People benefiting from the services provided by "Turkiye Klinikleri" and using the website can use the "SITE" only according to the law and only for personal reasons. Users have the criminal and civil liability for every process and action they take in the "SITE". Every USER agrees, declares and undertakes that they will not proceed by any function or action infringement of rights of "Turkiye Klinikleri"s and/or other third parties', they are the exclusive right holder on usage, processing, storage, made public and revealing any written, visual or auditory information reported to Turkiye Klinikleri" and/or "SITE" to the third parties. "USER" agrees and undertakes that s/he will not duplicate, copy, distribute, process, the pictures, text, visual and auditory images, video clips, files, databases, catalogs and lists within the "SITE", s/he will not be using these actions or with other ways to compete with "Turkiye Klinikleri", directly or indirectly.

4.3. The services provided and the context published within the "SITE" by third parties is not under the responsibility of "Turkiye Klinikleri", institutions collaborated with "Turkiye Klinikleri", "Turkiye Klinikleri" employee and directors, "Turkiye Klinikleri" authorized salespeople. Commitment to accuracy and legality of the published information, context, visual and auditory images provided by any third party are under the full responsibility of the third party. "Turkiye Klinikleri" does not promise and guarantee the safety, accuracy and legality of the services and context provided by a third party.

4.4. "USER"s cannot act against "Turkiye Klinikleri", other "USER"s and third parties by using the "SITE". "Turkiye Klinikleri" has no direct and/or indirect responsibility for any damage a third party suffered or will suffer regarding "USER"s actions on the "SITE" against the rules of the hereby "Terms of Use" and the law.

4.5. "USER"s accept and undertake that the information and context they provided to the "SITE" are accurate and legal. "Turkiye Klinikleri" is not liable and responsible for promising and guaranteeing the verification of the information and context transmitted to "Turkiye Klinikleri" by the "USER"s, or uploaded, changed and provided through the "SITE" by them and whether these information are safe, accurate and legal.

4.6. "USER"s agree and undertake that they will not perform any action leading to unfair competition, weakening the personal and commercial credit of "Turkiye Klinikleri" and a third party,  encroaching and attacking on personal rights within the "SITE" in accordance with the Turkish Commercial Code Law.

4.7. "Turkiye Klinikleri" reserves the right to change the services and the context within the "SITE"  anytime. "Turkiye Klinikleri" may use this right without any notification and timelessly. "USER"s have to make the changes and/or corrections "Turkiye Klinikleri" required immediately. Any changes and/or corrections that are required by "Turkiye Klinikleri", may be made by "Turkiye Klinikleri" when needed. Any harm, criminal and civil liability resulted or will result from changes and/or corrections required by "Turkiye Klinikleri" and were not made on time by the "USER"s belongs completely to the users.

4.8. "Turkiye Klinikleri" may give links through the "SITE" to other websites and/or "CONTEXT"s and/or folders that are outside of their control and owned and run by third parties. These links are provided for ease of reference only and do not hold qualification for support the respective web SITE or the admin or declaration or guarantee for the information inside. "Turkiye Klinikleri" does not hold any responsibility over the web-sites connected through the links on the "SITE", folders and context, the services or products on the websites provided through these links or their context.

4.9. "Turkiye Klinikleri" may use the information provided to them by the "USERS" through the "SITE" in line with the terms of the "PRIVACY POLICY" and "USER CONTRACT". It may process the information or classify and save them on a database. "Turkiye Klinikleri" may also use the USER's or visitor's identity, address, e-mail address, phone number, IP number, which sections of the "SITE" they visited, domain type, browser type, date and time information to provide statistical evaluation and customized services.

5. PROPRIETARY RIGHTS

5.1. The information accessed through this "SITE" or provided by the users legally and all the elements (including but not limited to design, text, image, html code and other codes) of the "SITE" (all of them will be called as studies tied to "Turkiye Klinikleri"s copyrights) belongs to "Turkiye Klinikleri". Users do not have the right to resell, process, share, distribute, display or give someone permission to access or to use the "Turkiye Klinikleri" services, "Turkiye Klinikleri" information and the products under copyright protection by "Turkiye Klinikleri". Within hereby "Terms of Use" unless explicitly permitted by "Turkiye Klinikleri" nobody can reproduce, process, distribute or produce or prepare any study from those under "Turkiye Klinikleri" copyright protection.

5.2. Within hereby "Terms of Use", "Turkiye Klinikleri" reserves the rights for "Turkiye Klinikleri" services, "Turkiye Klinikleri" information, the products associated with "Turkiye Klinikleri" copyrights, "Turkiye Klinikleri" trademarks, "Turkiye Klinikleri" trade looks or its all rights for other entity and information it has through this website unless it is explicitly authorized by "Turkiye Klinikleri".

6. CHANGES IN THE TERMS OF USE

"Turkiye Klinikleri" in its sole discretion may change the hereby "Terms of Use" anytime announcing within the "SITE". The changed terms of the hereby "Terms of Use" will become valid when they are announced. Hereby "Terms of Use" cannot be changed by unilateral declarations of users.

7. FORCE MAJEURE

"Turkiye Klinikleri" is not responsible for executing late or never of this hereby "Terms of Use", privacy policy and "USER Contract" in any situation legally taken into account as force majeure. Being late or failure of performance or non-defaulting of this and similar cases like this will not be the case from the viewpoint of "Turkiye Klinikleri", and "Turkiye Klinikleri" will not have any damage liability for these situations. "Force majeure" term will be regarded as outside of the concerned party's reasonable control and any situation that "Turkiye Klinikleri" cannot prevent even though it shows due diligence. Also, force majeure situations include but not limited to natural disasters, rebellion, war, strike, communication problems, infrastructure and internet failure, power cut and bad weather conditions.

8. LAW AND AUTHORISATION TO FOLLOW

Turkish Law will be applied in practicing, interpreting the hereby "Terms of Use" and managing the emerging legal relationships within this "Terms of Use" in case of finding element of foreignness, except for the rules of Turkish conflict of laws. Ankara Courts and Enforcement Offices are entitled in any controversy happened or may happen due to hereby contract.

9. CLOSING AND AGREEMENT

Hereby "Terms of Use" come into force when announced in the "SITE" by "Turkiye Klinikleri". The users are regarded to agree to hereby contract terms by using the "SITE". "Turkiye Klinikleri" may change the contract terms and the changes will be come into force by specifying the version number and the date of change on time it is published in the "SITE".

 

30.03.2014

Privacy Policy

We recommend you to read the terms of use below before you visit our website. In case you agree these terms, following our rules will be to your favor. Please read our Terms of Use thoroughly.

www.turkiyeklinikleri.com website belongs to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. and is designed in order to inform physicians in the field of health

www.turkiyeklinikleri.com cannot reach to user’s identity, address, service providers or other information. The users may send this information to the website through forms if they would like to. However, www.turkiyeklinikleri.com may collect your hardware and software information. The information consists of your IP address, browser type, operating system, domain name, access time, and related websites. www.turkiyeklinikleri.com cannot sell the provided user information (your name, e-mail address, home and work address, phone number) to the third parties, publish it publicly, or keep it in the website. Gathered information has a directing feature to be a source for the website’s visitor profile, reporting and promotion of the services.

www.turkiyeklinikleri.com uses the taken information:

-To enhance, improve and maintain the quality of the website

-To generate visitor’s profile and statistical data

-To determine the tendency of the visitors on using our website

-To send print publications/correspondences

-To send press releases or notifications through e-mail

-To generate a list for an event or competition

By using www.turkiyeklinikleri.com you are considered to agree that;

-Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. cannot be hold responsible for any user’s illegal and immoral behavior,

-Terms of use may change from time to time,

-It is not responsible for other websites’ contents it cannot control or the harms they may cause although it uses the connection they provided.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. may block the website to users in the following events:

-Information with wrong, incomplete, deceiving or immoral expressions is recorded to the website,

-Proclamation, advertisement, announcement, libelous expressions are used against natural person or legal identity,

-During various attacks to the website,

-Disruption of the website because of a virus.

Written, visual and audible materials of the website, including the code and the software are under protection by legal legislation.

Without the written consent of Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. the information on the website cannot be downloaded, changed, reproduced, copied, republished, posted or distributed.

All rights of the software and the design of the website belong to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. will be pleased to hear your comments about our terms of use. Please share the subjects you think may enrich our website or if there is any problem regarding our website.

info@turkiyeklinikleri.com